Eleftha 150mg Injection
Eleftha 150mg Injection
Trastuzumab (150mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Eleftha 150mg Injection contains Trastuzumab 150mg, a targeted therapy used in the treatment of certain types of HER2-positive cancers. It works by binding to specific HER2 receptors present on cancer cells, thereby slowing or stopping their growth and spread. This targeted action helps improve treatment effectiveness while minimizing damage to healthy cells. Trastuzumab is commonly used in the management of HER2-positive breast cancer and certain gastric cancers under specialized medical supervision. When administered as part of a prescribed treatment plan, Eleftha 150mg Injection helps support effective cancer therapy and disease management.
Active composition
Trastuzumab 150 mg
About Trastuzumab
Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer. It inhibits cancer cell growth and promotes cell death. Its clinical relevance lies in managing specific breast cancer types. In summary, Trastuzumab is essential for treating HER2-positive breast cancer.
How It Works
Trastuzumab binds to the HER2 receptor, inhibiting signaling pathways that promote cancer cell proliferation.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Eleftha 150mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Eleftha 150mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Eleftha 150mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Eleftha 150mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Eleftha 150mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Eleftha 150mg Injection in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Eleftha 150mg Injection
